Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders

被引:17
|
作者
Pinna, Federica [1 ]
Deriu, Luca [1 ]
Lepori, Tiziana [1 ]
Maccioni, Raffaela [1 ]
Milia, Paola [1 ]
Sarritzu, Elisabetta [1 ]
Tusconi, Massimo [1 ]
Carpiniello, Bernardo [1 ]
机构
[1] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Sect Psychiat, I-09127 Cagliari, Italy
关键词
Remission; Symptomatology; Functioning; Quality of life; Subjective well-being; Schizophrenia; Schizoaffective disorders; QUALITY-OF-LIFE; SYMPTOMATIC REMISSION; FUNCTIONAL REMISSION; CRITERIA; SCALE; RELIABILITY; ADHERENCE; PSYCHOSIS;
D O I
10.1016/j.psychres.2013.08.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
To date, few studies have reported analytical data relating to clinical remission, functional remission and subjective experience. The present study aimed to investigate these aspects in a sample of chronic outpatients. Methods: 112 schizophrenic or schizoaffective outpatients (Males=60; Females=52; mean age 43.5 +/- 9.42 yr) were evaluated with regard to symptomatology (SCID-I; PANSS, CGI-SCH scales), functioning (PSP scale), subjective wellbeing (SWN-K scale) and Quality of Life (WHO-QoL-Bref scale). Results: 50% of patients were found to be in remission. Significantly higher scores at PANNS, CGI-SCH, PSP, but not at SWN and WHO-QoL, were found among remitted patients; a relevant proportion of remitted subjects continued to manifest a moderate level of symptoms (score >3) both at PANSS (35% of cases) and CGI-SCH (29% of cases), significant functional impairment (total score <70) at PSP (68% of cases), and a lesser degree of wellbeing (total score <80) at SWN-K (34% of cases). Conclusion: patients in whom clinical remission was confirmed may display persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:739 / 744
页数:6
相关论文
共 50 条
  • [41] Maintenance medication for schizophrenia and schizoaffective patients
    Lerner, V
    Fotyanov, M
    Liberman, M
    Shlafman, M
    BarEl, Y
    [J]. SCHIZOPHRENIA BULLETIN, 1995, 21 (04) : 693 - 701
  • [42] LYMPHOCYTE SUBSETS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE PATIENTS
    MENON, P
    MENON, V
    IBRAHIM, G
    NICHOLS, G
    HILMAN, B
    GELDER, F
    SEBASTIAN, S
    [J]. ANNALS OF ALLERGY, 1988, 60 (02): : 182 - 182
  • [43] Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders
    Perkins, DO
    Lieberman, JA
    Gu, H
    Tohen, M
    McEvoy, JP
    Green, AI
    Zipursky, RB
    Strakowski, SM
    Sharma, T
    Kahn, R
    Gur, RE
    Tollefson, GD
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 182S - 183S
  • [44] Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and Schizoaffective disorders
    Gorobets, LN
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 140 (06) : 714 - 715
  • [45] Comparison of Clinical and Sociodemographic Profiles Between Patients with Bipolar Disorder and Schizophrenia/schizoaffective Disorders
    Sobreira, G.
    Oliveira, J. M.
    Aleixo, M. A.
    Brissos, S.
    Carnot, M. J.
    Nobre, M. A.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [46] Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders
    Perkins, DO
    Lieberman, JA
    Gu, H
    Tohen, M
    McEvoy, J
    Green, A
    Zipursky, R
    Strakowski, SM
    Sharma, T
    Kahn, R
    Gur, R
    Tollefson, G
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 24 - 24
  • [47] Remission in schizophrenia: 1 year Italian study with risperidone long-acting injectable (RLAI) in subjects with schizophrenia or schizoaffective disorder
    Rossi, A.
    Bernareggi, M. M.
    Giustra, M. G.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S167 - S167
  • [48] Unconjugated bilirubin and acute psychosis: a five years retrospective observational and controlled study in patients with schizophrenia, schizoaffective and bipolar disorders
    Marques, Joao Gama
    Pedro, Isaias
    Ouakinin, Silvia
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2019, 23 (04) : 281 - 285
  • [49] Remitted Male Schizophrenia Patients with Sexual Dysfunction
    Yee, Ong Kheng
    Ramli, Eni Rahaiza Muhd
    Ismail, Hasanah Che
    [J]. JOURNAL OF SEXUAL MEDICINE, 2014, 11 (04): : 956 - 965
  • [50] CLOZAPINE IN THE TREATMENT OF PSYCHOTIC MOOD DISORDERS, SCHIZOAFFECTIVE DISORDER, AND SCHIZOPHRENIA
    MCELROY, SL
    DESSAIN, EC
    POPE, HG
    COLE, JO
    KECK, PE
    FRANKENBERG, FR
    AIZLEY, HG
    OBRIEN, S
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 (10) : 411 - 414